medigraphic.com

2017, Number 2

<< Back Next >>

Rev Med MD 2017; 8.9 (2)

Hepatoblastoma and inferior vena cava resection in a toddler

Martínez-Flores JG, Montes-Tapia F, Granados-Hernández DM, Mares-Gil JE

Language: Spanish
References: 16
Page: 177-181
PDF size: 594.27 Kb.


ABSTRACT

The hepatoblastoma is the hepatic tumor more prevalent in infancy. The stage of the hepatoblastoma is based upon the PRETEXT system. Stage IV is considered not surgical and confers the worst prognosis. The treatment of this stage is based in neoadjuvant quimiotherapy and posterior partial or total hepatectomia plus hepatic transplantation, accordingly with the POSTEXT.
We report the case of a toddler with stage IV quimiosensitive hepatoblastoma, with invasion of the retrohepatic vena cava and pulmonary metastasis who underwent a right trisegmentectomy with resection of the retrohepatic vena cava. This procedure was allowed by the presence of collateral circulation provide for the acigus vena, offering a curative option for our patient.
The resection of the retrohepatic vena cava could be a feasible and useful alternative to allow partial hepatectomia with clean boards, and offer a potential cure in selected patients


REFERENCES

  1. Kremer N, Walther AE, Tiao GM. Management of hepatoblastoma: an update. Curr Opin Pediatr. 2014;26(3):362–9.

  2. Otte J-B. Progress in the surgical treatment of malignant liver tumors in children. Cancer Treat Rev. 2010;36(4):360–71.

  3. Rodriguez-Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, et al. Children's Oncology Group's 2013 blueprint for research: rare tumors. Pediatr Blood Cancer. 2013 ;60(6):1016–21.

  4. Das CJ, Dhingra S, Gupta AK, Iyer V, Agarwala S. Ima g ing of pa edia tric liver tumours with pathological correlation. Clin Radiol. 2009;64(10):1015–25.

  5. Maibach R, Roebuck D, Brugieres L, Capra M, Brock P, Dall'Igna P, et al. Prognostic stratification for children with hepatoblastoma: The SIOPEL experience. Eur J Cancer. 2012;48(10):1543–9.

  6. Warmann SW, Schenk A, Schaefer JF, Ebinger M, Blumenstock G, Tsiflikas I, et al. Computer-assisted surgery planning in children with complex liver tumors identifies variability of the classical Couinaud classification. JPediatr Surg. 2016;51(11):1801–6.

  7. Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, et al. Guidelines for surgical treatment of hepatoblastoma in the modern era - Recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer. 2005;41(7):1031–6.

  8. Hishiki T. Current therapeutic strategies for childho odhe patictumors: surgical and interventional treatments for hepatoblastoma. Int J Clin Oncol. 2013;18(6):962–8.

  9. Malogolowkin MH, Katzenstein HM, Krailo M, Meyers RL. Treatment of hepatoblastoma: the North American cooperative group experience. Front Biosci (Elite Ed). 2012;4:1717–23.

  10. Haeberle B, Schweinitz D von. Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies. Front Biosci (Elite Ed) [Internet]. 2012 [cited 2016 Aug 9];4:493–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22201890

  11. Towu E, Kiely E, Pierro A, Spitz L, Losty P. Outcome and Complications after Resection of Hepatoblastoma. JPediatr Surg. 2004;39(2):199–202.

  12. Meyers RL, Tiao G, de Ville de Goyet J, Superina R, Aronson DC. Hepatoblastoma state of the art. Curr Opin Pediatr. 2014;26(1):29–36.

  13. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer. 2004;42(1):74–83.

  14. Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, et al. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg. 2015;102(1):108–13.

  15. Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, et al. Successful treatment of childhood high-risk hepatoblastoma with doseintensive multiagent chemotherapy and surgery: Final results of the SIOPEL-3HR study. J Clin Oncol. 2010;28(15):2584–90.

  16. Uotani H, Yamashita Y, Masuko Y, Shimoda M, Murakami A, Sakamoto T, et al. A case of resection under the IVC-atrial venovenous bypass of a hepatoblastoma after intraarterial chemotherapy. J Pediatr Surg. 1998;33(4):639–41.




2020     |     www.medigraphic.com